Inventor · disambiguated record
Michael Wiedmann
Also filed as: WIEDMANN MICHAEL
10 granted patents·5 pending applications·220 citations·filing 1995–2022
91Inventor score
Files withROCHE DIAGNOSTICS GMBH7BOEHRINGER MANNHEIM GMBH3GENENTECH INC2HOFFMANN LA ROCHE1SEIDEL CHRISTOPH1
Top patents by PatentIndex Score
15 records- 0189US5863740AInterference eliminating agent for application in immunoassaysBOEHRINGER MANNHEIM GMBH·Filed 1995·Granted Jan 26, 1999·63 cites·25 claims
- 0282US6613530B1Determination of a specific immunoglobulin using multiple antigensROCHE DIAGNOSTICS GMBH·Filed 1995·Granted Sep 2, 2003·57 cites·21 claims
- 0381US12503487B2Method for the reduction of host cell proteins in affinity chromatographyGENENTECH INC·Filed 2021·Granted Dec 23, 2025·1 cites·14 claims
- 0475US6306579B1Recombinant antigen from the NS3 region of the hepatitis C virusROCHE DIAGNOSTICS GMBH·Filed 1997·Granted Oct 23, 2001·24 cites·17 claims
- 0575US6270960B1Recombinant antigen from the NS3 region of the hepatitis C virusROCHE DIAGNOSTICS GMBH·Filed 2000·Granted Aug 7, 2001·5 cites·15 claims
- 0671US6096319ARecombinant antigen from the NS3 region of the hepatitis C virusROCHE DIAGNOSTICS GMBH·Filed 1995·Granted Aug 1, 2000·19 cites·9 claims
- 0768US5804391AElimination of rheumatoid factor interference using anti-FD antibodiesBOEHRINGER MANNHEIM GMBH·Filed 1995·Granted Sep 8, 1998·33 cites·15 claims
- 0865US7122302B2Method for determining early HCV seroconversionROCHE DIAGNOSTICS GMBH·Filed 2001·Granted Oct 17, 2006·1 cites·9 claims
- 0962US2009098528A1Method for determining early HCV seroconversionSEIDEL CHRISTOPH·Filed 2007·Application pending·0 cites
- 1059US7629295B2Determination of a specific immunoglobulin using multiple antigensROCHE DIAGNOSTICS GMBH·Filed 2003·Granted Dec 8, 2009·2 cites·18 claims
- 1159US2010136519A1Determination of a specific immunoglobulin using multiple antigensROCHE DIAGNOSTICS GMBH·Filed 2009·Application pending·0 cites
- 1257US2005095584A1Method for determining early HCV seroconversionFiled 2004·Application pending·0 cites
- 1356US2023358748A1Method for the determination of hydrolytic activityHOFFMANN LA ROCHE·Filed 2022·Application pending·0 cites
- 1451US2018186832A1Method for the reduction of host cell proteins in affinity chromatographyGENENTECH INC·Filed 2018·Application pending·0 cites
- 1548US5952185APhoto-activatable biotin derivatives and their use to reduce interference in immunoassaysBOEHRINGER MANNHEIM GMBH·Filed 1997·Granted Sep 14, 1999·15 cites·17 claims
Join the waitlist — get patent alerts
Get an alert when Michael Wiedmann files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →